by: xpoolPosted on:

Hyperliquid Doubles Down on HYPE Investment, Raises $1 Billion for Further Purchases

Hyperliquid Strategies is taking a significant step forward in its investment strategy by securing a $1 billion funding round to bolster its holdings of the HYPE token. This strategic move comes as the company prepares for the merger with Sonnet BioTherapeutics and Rorschach I LLC, a combination expected to yield a leading presence within the decentralized derivatives space.

Related posts:

  1. HYPE Token Reaches $50 as Hyperliquid Breaks Records
  2. Hyperliquid Sees Bullish Breakout and Growing Institutional Interest
  3. HYPE Token Gains Momentum with Hyperliquid’s HIP-3 Launch
  4. Hyperliquid Strategies Raises $1 Billion to Expand HYPE Token Reach